Source: SCITECH DAILY, 10/4/21



An investigation into the origins of the sensation of pain has led to the development of a novel and durable treatment for inflammatory pain that could be a promising alternative to opioids. The preclinical research was conducted by neuroscientists and pharmacologists, all in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo. It was published today (October 4, 2021) in Nature Communications. The research has led to UB filing patents on two sets of novel lipidated peptides — peptides modified with lipid molecules — that are injected at the site of injury.

For more of this story, click here.